112 related articles for article (PubMed ID: 2790740)
1. Characterization of three human malignant mesothelioma cell lines.
Versnel MA; Hoogsteden HC; Hagemeijer A; Bouts MJ; van der Kwast TH; Delahaye M; Schaart G; Ramaekers FC
Cancer Genet Cytogenet; 1989 Oct; 42(1):115-28. PubMed ID: 2790740
[TBL] [Abstract][Full Text] [Related]
2. Serum-dependent growth patterns of two, newly established human mesothelioma cell lines.
Klominek J; Robért KH; Hjerpe A; Wickström B; Gahrton G
Cancer Res; 1989 Nov; 49(21):6118-22. PubMed ID: 2790824
[TBL] [Abstract][Full Text] [Related]
3. Phenotypes and karyotypes of human malignant mesothelioma cell lines.
Relan V; Morrison L; Parsonson K; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Fong KM; Bowman RV
PLoS One; 2013; 8(3):e58132. PubMed ID: 23516439
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of nine newly derived mesothelioma cell lines.
Pass HI; Stevens EJ; Oie H; Tsokos MG; Abati AD; Fetsch PA; Mew DJ; Pogrebniak HW; Matthews WJ
Ann Thorac Surg; 1995 Apr; 59(4):835-44. PubMed ID: 7695406
[TBL] [Abstract][Full Text] [Related]
5. Establishment of three novel human malignant pleural mesothelioma cell lines: morphological and cytogenetical studies and EGFR mutation status.
Kobayashi M; Takeuchi T; Ohtsuki Y
Anticancer Res; 2008; 28(1A):197-208. PubMed ID: 18383846
[TBL] [Abstract][Full Text] [Related]
6. [Clonal chromosome abnormalities in a case of pleural mesothelioma].
Pegoraro M; Bersi M; Gasparini C; Cardini G; Ruffoni A
Arch Sci Med (Torino); 1973; 130(2):125-30. PubMed ID: 17342920
[TBL] [Abstract][Full Text] [Related]
7. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients.
Pelin-Enlund K; Husgafvel-Pursiainen K; Tammilehto L; Klockars M; Jantunen K; Gerwin BI; Harris CC; Tuomi T; Vanhala E; Mattson K
Carcinogenesis; 1990 Apr; 11(4):673-81. PubMed ID: 2323006
[TBL] [Abstract][Full Text] [Related]
8. Establishment of human malignant mesothelioma cell lines.
Versnel MA; Bouts MJ; Hoogsteden HC; van der Kwast TH; Delahaye M; Hagemeijer A
Int J Cancer; 1989 Aug; 44(2):256-60. PubMed ID: 2474517
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic analysis of malignant mesothelioma.
Hagemeijer A; Versnel MA; Van Drunen E; Moret M; Bouts MJ; van der Kwast TH; Hoogsteden HC
Cancer Genet Cytogenet; 1990 Jul; 47(1):1-28. PubMed ID: 2357680
[TBL] [Abstract][Full Text] [Related]
10. Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma. A comparison to conventional karyotyping and flow cytometric studies.
Tiainen M; Hopman A; Moesker O; Ramaekers F; Wessman M; Laasonen A; Pyrhönen S; Tammilehto L; Mattson K; Knuutila S
Cancer Genet Cytogenet; 1992 Sep; 62(2):171-9. PubMed ID: 1394105
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions.
Manning LS; Whitaker D; Murch AR; Garlepp MJ; Davis MR; Musk AW; Robinson BW
Int J Cancer; 1991 Jan; 47(2):285-90. PubMed ID: 1703129
[TBL] [Abstract][Full Text] [Related]
12. Further analyses of the evolutionary characteristics of a sequentially studied human malignant mesothelioma.
Mark J; Olofsson K; Månsson T; Stenman G
Hereditas; 1989; 110(1):85-6. PubMed ID: 2777632
[No Abstract] [Full Text] [Related]
13. Establishment of four new mesothelioma cell lines: characterization by ultrastructural and immunophenotypic analysis.
Orengo AM; Spoletini L; Procopio A; Favoni RE; De Cupis A; Ardizzoni A; Castagneto B; Ribotta M; Betta PG; Ferrini S; Mutti L
Eur Respir J; 1999 Mar; 13(3):527-34. PubMed ID: 10232421
[TBL] [Abstract][Full Text] [Related]
14. High CD44 expression on human mesotheliomas mediates association with hyaluronan.
Penno MB; Askin FB; Ma H; Carbone M; Vargas MP; Pass HI
Cancer J Sci Am; 1995; 1(3):196-203. PubMed ID: 9166476
[TBL] [Abstract][Full Text] [Related]
15. Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis.
Philippeaux MM; Pache JC; Dahoun S; Barnet M; Robert JH; Mauël J; Spiliopoulos A
Histochem Cell Biol; 2004 Sep; 122(3):249-60. PubMed ID: 15372243
[TBL] [Abstract][Full Text] [Related]
16. del(6q) as a possible primary change in malignant mesothelioma.
Meloni AM; Stephenson CF; Li FP; Sandberg AA
Cancer Genet Cytogenet; 1992 Mar; 59(1):57-61. PubMed ID: 1555192
[TBL] [Abstract][Full Text] [Related]
17. Establishment and characterization of human malignant pleural mesothelioma cell line SMC-1.
Wu SF; Wang EZ; Su JZ; Xu HX; Lin ZQ; Sheng CF; Xu CW; Chen RM; Ye XZ; Zhu DH
Sci Sin B; 1985 Mar; 28(3):281-8. PubMed ID: 3159086
[TBL] [Abstract][Full Text] [Related]
18. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.
Blobel GA; Moll R; Franke WW; Kayser KW; Gould VE
Am J Pathol; 1985 Nov; 121(2):235-47. PubMed ID: 2414994
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic analysis of effusions from malignant mesothelioma. A diagnostic adjunct to cytology.
Granados R; Cibas ES; Fletcher JA
Acta Cytol; 1994; 38(5):711-7. PubMed ID: 8091903
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructure of pleural mesothelioma and pulmonary adenocarcinoma in malignant effusions as compared with reactive mesothelial cells.
Sakuma N; Kamei T; Ishihara T
Acta Cytol; 1999; 43(5):777-85. PubMed ID: 10518130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
